Explore 3 Stock Ideas & Industry Insights Download Free Report

Announcements

Addus HomeCare Officer David Tucker Plans to Sell 14,850 Shares

Addus HomeCare Corporation officer David Tucker filed a Form 144 notice of proposed sale on November 6, 2026, covering 14,850 shares of common stock with an aggregate market value of $1,852,566.40.

Vinay Lochav | 06 November 2026

Cliff Blessing Plans to Sell 2,000 Addus HomeCare Shares

Addus HomeCare Corporation officer Cliff Blessing filed a Form 144 notice on November 6, 2026, disclosing a proposed sale of 2,000 shares of Addus HomeCare common stock through Morgan Stanley Smith Barney LLC.

Nitish Kishor | 06 November 2026

Prudential Officer Boyle Files to Sell 2,876 Shares via Option Exercise

Robert E. Boyle, an officer of Prudential Financial Inc, filed a Form 144 notice of proposed sale of 2,876 shares of common stock on November 6, 2026, through broker Morgan Stanley Smith Barney LLC Securities Executive Services.

Shwetambri Chauhan | 06 November 2026

Sean Woodroffe Plans to Sell 17,500 Lincoln National Shares

Lincoln National Corporation officer Sean Woodroffe filed a Form 144 notice of proposed sale on November 6, 2026, covering 17,500 shares of Lincoln National common stock to be sold through J.P. Morgan Securities LLC on NYSE.

Shwetambri Chauhan | 06 November 2026

Bechtolsheim Files to Sell 260,000 Arista Networks Shares

Andreas Bechtolsheim, a 10% stockholder of Arista Networks, Inc., filed a Form 144 notice of proposed sale of 260,000 shares of common stock, with an approximate sale date of November 6, 2026, through Goldman Sachs & Co. LLC on the NYSE.

Manish Choudhary | 06 November 2026

Raju Prasad Files Form 144 to Sell 79,393 CRISPR Therapeutics Shares

CRISPR Therapeutics AG officer Raju Prasad filed a Form 144 notice of proposed sale of 79,393 common shares on November 6, 2026, with an aggregate market value of $3,960,183.20, to be executed through Morgan Stanley Smith Barney LLC.

Shwetambri Chauhan | 06 November 2026

CRISPR Therapeutics CTO Sakhamuri Gets 90,000 Options, 40,000 RSUs

Sivakesava Sakhamuri, Chief Technical Officer of CRISPR Therapeutics AG, filed a Form 4 on November 6, 2026, disclosing the acquisition of stock options covering 90,000 common shares and a restricted stock unit award covering 40,000 common shares, both granted on November 4, 2026.

Shwetambri Chauhan | 06 November 2026

Skyworks Officer Robert Terry Plans Sale of 43,374 Shares

Skyworks Solutions, Inc. officer Robert Terry filed a Form 144 notice on November 6, 2026, disclosing a proposed sale of 43,374 shares of common stock with an aggregate market value of $3,576,639.30.

Nitish Kishor | 06 November 2026

Brenna Preisser Files to Sell 4,300 Brunswick Shares

Brunswick Corporation officer Brenna Preisser filed a Form 144 notice of proposed sale with the SEC on November 6, 2026, covering 4,300 shares of Brunswick common stock with an aggregate market value of $334,601.92.

Aakashdeep | 06 November 2026

Motorola Solutions Officer Niewiara Files to Sell 183 Shares

Matthew A. Niewiara, an officer of Motorola Solutions, Inc., filed a Form 144 notice of proposed sale of securities on November 6, 2026, covering 183 shares of common stock with an aggregate market value of $94,276.11.

Anjali Anand | 06 November 2026
Support

Hi! How can we help you today?

Loading…